%0 Journal Article %A Andres Garchitorena %A Felana A Ihantamalala %A Christophe RĂ©villion %A Laura F Cordier %A Mauricianot Randriamihaja %A Benedicte Razafinjato %A Feno H Rafenoarivamalala %A Karen E. Finnegan %A Jean-Claude Andrianirinarison %A Julio Rakotonirina %A Vincent Herbreteau %A Matthew H Bonds %T Geographic Barriers to Achieving Universal Health Coverage in a rural district of Madagascar %D 2020 %R 10.1101/2020.07.15.20155002 %J medRxiv %P 2020.07.15.20155002 %X Poor geographic access can persist even when affordable and well-functioning health systems are in place, limiting efforts for universal health coverage (UHC). It is unclear how health facilities and community health workers contribute to achieving UHC. Using geographic information from thousands of patients in a rural district of Madagascar we evaluate how a health system strengthening (HSS) intervention aimed towards UHC affects the geography of primary care access. We find that facility-based interventions (user-fee exemptions, improved readiness) achieved high utilization rates only among populations who lived in close proximity to supported facilities. Scaling only facility-based HSS programs across the district would result in large gaps in health care access for the majority of the population. Community health provided major improvements in service utilization for children regardless of their distance from facilities. Our results have implications for UHC policies and suggest that greater emphasis on professionalized community health programs is essential.Competing Interest StatementSome authors are current or former employees of institutions discussed in this article, including the non-governmental organization PIVOT and the Government of Madagascar. These affiliations are explicitly listed in the article.Funding StatementThis work was supported by a grant from Institut de Recherche pour le Developpement (Coup de Pouce) and internal funding from PIVOT.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Use of MoH data for this study was authorized by the Secretary General of the MoH, by the Medical Inspector of Ifanadiana district. The study was approved by Harvard Institutional Review board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData belongs to the Madagascar Ministry of Public Health. For data requests, please contact research@pivotworks.org %U https://www.medrxiv.org/content/medrxiv/early/2020/07/17/2020.07.15.20155002.full.pdf